These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18384283)

  • 21. Popular ergogenic drugs and supplements in young athletes.
    Calfee R; Fadale P
    Pediatrics; 2006 Mar; 117(3):e577-89. PubMed ID: 16510635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Putative effects of doping in cycling].
    Kuipers H
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2643-5. PubMed ID: 17205940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An alternative consideration in drug testing in elite athletes.
    Legge M; Fitzgerald R; Jones L
    N Z Med J; 2008 Jul; 121(1278):73-7. PubMed ID: 18670476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of the physiological response to simulated altitude exposure and r-HuEpo administration.
    Ashenden MJ; Hahn AG; Martin DT; Logan P; Parisotto R; Gore CJ
    J Sports Sci; 2001 Nov; 19(11):831-7. PubMed ID: 11695504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood doping: Then and now. A narrative review of the history, science and efficacy of blood doping in elite sport.
    Atkinson TS; Kahn MJ
    Blood Rev; 2020 Jan; 39():100632. PubMed ID: 31645265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemoglobin mass in cyclists during stage racing.
    Schumacher YO; Pottgiesser T; Ahlgrim C; Ruthardt S; Dickhuth HH; Roecker K
    Int J Sports Med; 2008 May; 29(5):372-8. PubMed ID: 17614021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Swedish Blood Pass project.
    Berglund B; Ekblom B; Ekblom E; Berglund L; Kallner A; Reinebo P; Lindeberg S
    Scand J Med Sci Sports; 2007 Jun; 17(3):292-7. PubMed ID: 17501870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Gene doping: gene transfer and possible molecular detection].
    Argüelles CF; Hernández-Zamora E
    Gac Med Mex; 2007; 143(2):169-72. PubMed ID: 17585706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Doping in endurance sports. Survey of individual [Hb] levels can expose doping].
    Ekblom B; Holmberg HC; Eriksson K
    Lakartidningen; 2001 Nov; 98(48):5490-2, 5495-6. PubMed ID: 11769364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N; Wojek N
    Int J Sports Med; 2008 Jun; 29(6):524-8. PubMed ID: 18027309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of drugs in swimming.
    Puffer JC
    Clin Sports Med; 1986 Jan; 5(1):77-89. PubMed ID: 3512106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.
    Elliott S
    Br J Pharmacol; 2008 Jun; 154(3):529-41. PubMed ID: 18362898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ergogenic aids: a review of basic science, performance, side effects, and status in sports.
    Tokish JM; Kocher MS; Hawkins RJ
    Am J Sports Med; 2004 Sep; 32(6):1543-53. PubMed ID: 15310585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Blood doping: 2].
    Cristani A; Boldrini E; Amateis E; Arioli D
    Recenti Prog Med; 2005 Jan; 96(1):1-3. PubMed ID: 15789630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developing strategies for detection of gene doping.
    Baoutina A; Alexander IE; Rasko JE; Emslie KR
    J Gene Med; 2008 Jan; 10(1):3-20. PubMed ID: 18081214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance-enhancing drugs and supplements in women and girls.
    Matich AJ
    Curr Sports Med Rep; 2007 Dec; 6(6):387-91. PubMed ID: 18001612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New drugs and methods of doping and manipulation.
    Thevis M; Kohler M; Schänzer W
    Drug Discov Today; 2008 Jan; 13(1-2):59-66. PubMed ID: 18190865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.